Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,767,875
-$90,803,744 QoQ
Shares Held
99,106
-67.7% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$11,859,600
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in UTHR
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,859,600 | 20,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $58,767,875 | 99,106 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $584,700 | 1,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $149,571,619 | 306,971 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,173,788 | 2,800 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $27,127,498 | 64,711 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,209,058 | 21,608 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,330,099 | 30,266 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $529,260 | 1,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $15,273,737 | 43,288 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,472,942 | 51,550 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,385,788 | 42,021 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,701,534 | 42,232 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $19,723,912 | 89,699 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $19,218,374 | 85,086 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,607,456 | 88,822 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,564,138 | 167,727 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $45,415,433 | 163,312 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,705,184 | 36,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,649,604 | 87,632 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,818,283 | 99,316 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $38,831,087 | 179,707 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $1,210,048 | 5,600 | Call | Defined | 2022-02-14 | |
| 2021-09-30 | $53,053,275 | 287,427 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $69,888,805 | 389,548 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,468,988 | 373,462 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $73,514,324 | 484,316 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $66,625,256 | 659,656 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $60,536,542 | 500,302 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $56,300,380 | 593,698 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||